Business
US Trade Policy and Market Impact
President Trump's generic drug tariff plan sparks concerns over medicine prices and manufacturing. Meanwhile, GE Vernova's stock declines despite a revenue outlook upgrade.
Coverage timeline — 2 articles
CNBC
Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.
2026-07-22 13:16 UTC
MarketWatch
The stock declined nearly 5% despite the energy company upgrading its guidance for 2026 revenue by $1 billion.
2026-07-22 13:26 UTC